HDDO-1614

· Hyundai Pharmaceutical Co., LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HDDO-1614, covering 2017-12-11 to 2018-02-26. Get the full timeline:

Most recent: Clinical Trial Update: HDDO-1614 Bio Equivalence Study [Phase 1]